Did the obesity treatment ‘Belviq’ become a blockbuster product in 2 months since its launch?
The Ildong Pharmaceutical’s ambitious work, Belviq, has been unveiled. As a result, the news was that it has recorded KRW 5.3 billion sales in 2 months since its launch. However, it seems to look into a little more carefully to grasp the certainty.
It is explained that although a report of a fin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
